Mauro Papotti

7.8k citations

96 papers · 4.6k indexed · 1 hit paper · h-index 37

Pulmonary and Respiratory Medicine top 0.5%
- Lung Cancer Treatments and Mutations 35
- Occupational and environmental lung diseases 17
- Medical Imaging and Pathology Studies 17
- Prostate Cancer Treatment and Research 16
- Prostate Cancer Diagnosis and Treatment 12
- Lung Cancer Diagnosis and Treatment 12
Cancer Research top 2%
- Cancer Genomics and Diagnostics 15
Oncology top 1%
- Lung Cancer Research Studies 13
Nephrology top 5%
Molecular Biology top 5%

Co-authors: Giorgio V. Scagliotti Paolo Ceppi Silvia Novello Luisella Righi Marco Volante Giulio Rossi Giuseppe Pelosi Marco Lo Iacono
Cited by: Pulmonary and Respiratory Medicine Cancer Research Oncology
Journals: Proceedings of the National Academy of Sciences (1 paper)The Lancet (1 paper)Journal of Clinical Oncology (2 papers)
Partner nations: Italy United States Japan

In The Last Decade

Mauro Papotti

96 papers receiving 4.5k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Mauro Papotti

Since Specialization

Citations

This map shows the geographic impact of Mauro Papotti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mauro Papotti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mauro Papotti more than expected).

Fields of papers citing papers by Mauro Papotti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mauro Papotti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mauro Papotti. The network helps show where Mauro Papotti may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mauro Papotti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mauro Papotti Line = papers co-authored together Mauro Papotti links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Full cost of diagnostic pathology for lung carcinoma in Italy: results from four Pathology Units Pathologica ·Carlo Lazzaro,Giovanni Fattore,Massimo Barberis,Fiamma Buttitta,Paola Cassoni,Paolo Graziano,Antonio Marchetti,Stefania Crema,Francesca Dal Pero,Mauro Papotti	2023	2
2	Micro-RNA-215 and -375 regulate thymidylate synthase protein expression in pleural mesothelioma and mediate epithelial to mesenchymal transition Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·Francesca Napoli,Ida Rapa,Stefania Izzo,Angelica Rigutto,Roberta Libener,Chiara Riganti,Paolo Bironzo,Riccardo Taulli,Mauro Papotti,Marco Volante,Giorgio V. Scagliotti,Luisella Righi	2022	2
3	Pathological Characterization of Tumor Immune Microenvironment (TIME) in Malignant Pleural Mesothelioma Cancers ·Francesca Napoli,Angela Listì,Vanessa Zambelli,Gianluca Witel,Paolo Bironzo,Mauro Papotti,Marco Volante,Giorgio V. Scagliotti,Luisella Righi	2021	16
4	The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015breakdown → Journal of Thoracic Oncology ·Andrew G. Nicholson,Ming‐Sound Tsao,Mary Beth Beasley,Alain Borczuk,Élisabeth Brambilla,Wendy A. Cooper,Sanja Đačić,Deepali Jain,Keith M. Kerr,Sylvie Lantuéjoul,Masayuki Noguchi,Mauro Papotti,Natasha Rekhtman,Giorgio V. Scagliotti,Paul Van Schil,Lynette M. Sholl,Yasushi Yatabe,Akihiko Yoshida,William D. Travis	2021	752
5	Antagonists of growth hormone-releasing hormone (GHRH) inhibit the growth of human malignant pleural mesothelioma Proceedings of the National Academy of Sciences ·Tania Villanova,Iacopo Gesmundo,Valentina Audrito,Nicoletta Vitale,Francesca Silvagno,Chiara Musuraca,Luisella Righi,Roberta Libener,Chiara Riganti,Paolo Bironzo,Silvia Deaglio,Mauro Papotti,Renzhi Cai,Wei Sha,Ezio Ghigo,Andrew V. Schally,Riccarda Granata	2019	28
6	DNA methylation in repeat negative prostate biopsies as a marker of missed prostate cancer Clinical Epigenetics ·Valentina Fiano,Daniela Zugna,Chiara Grasso,Morena Trevisan,Luisa Delsedime,Luca Molinaro,Paola Cassoni,Mauro Papotti,Franco Merletti,Olof Akre,Andreas Pettersson,Laura De Marco,Lorenzo Richiardi	2019	9
7	ALK Rearrangement Testing by FISH Analysis in Non–Small-Cell Lung Cancer Patients: Results of the First Italian External Quality Assurance Scheme Journal of Thoracic Oncology ·Antonio Marchetti,Massimo Barberis,Mauro Papotti,Giulio Rossi,Renato Franco,Sara Malatesta,Fiamma Buttitta,Andrea Ardizzoni,Lucio Crinò,Cesare Gridelli,Gian Luigi Taddei,Claudio Clemente,Giorgio V. Scagliotti,Nicola Normanno,Carmine Pinto	2014	16
8	Targeted Next-Generation Sequencing of Cancer Genes in Advanced Stage Malignant Pleural Mesothelioma: A Retrospective Study Journal of Thoracic Oncology ·Marco Lo Iacono,Valentina Monica,Luisella Righi,Federica Grosso,Roberta Libener,Simona Vatrano,Paolo Bironzo,Silvia Novello,Loredana Musmeci,Marco Volante,Mauro Papotti,Giorgio V. Scagliotti	2014	114
9	Recommendations for the Analysis of ALK Gene Rearrangements in Non–Small-Cell Lung Cancer: A Consensus of the Italian Association of Medical Oncology and the Italian Society of Pathology and Cytopathology Journal of Thoracic Oncology ·Antonio Marchetti,Andrea Ardizzoni,Mauro Papotti,Lucio Crinò,Giulio Rossi,Cesare Gridelli,Massimo Barberis,Eugenio Maiorano,Nicola Normanno,Gian Luigi Taddei,Giorgio V. Scagliotti,Claudio Clemente,Carmine Pinto	2013	40
10	Human ASH-1 Promotes Neuroendocrine Differentiation in Androgen Deprivation Conditions and Interferes With Androgen Responsiveness in Prostate Cancer Cells The Prostate ·Ida Rapa,Marco Volante,Cristina Migliore,Antonella Farsetti,Alfredo Berruti,Giorgio V. Scagliotti,Silvia Giordano,Mauro Papotti	2013	26
11	Biopsy and radical prostatectomy pathological patterns influence Prostate cancer gene 3 (PCA3) score. PubMed ·Stefano De Luca,Roberto Passera,Enrico Bollito,Angela Milillo,Roberto Mario Scarpa,Mauro Papotti,R Coda,Donato Randone	2013	5
12	The challenge of NSCLC diagnosis and predictive analysis on small samples. Practical approach of a working group Lung Cancer ·Erik Thunnissen,Keith M. Kerr,Felix Herth,Sylvie Lantuéjoul,Mauro Papotti,Robert C. Rintoul,Giulio Rossi,Birgit Guldhammer Skov,Birgit Weynand,Lukas Bubendorf,Katrien Grünberg,Leif Johansson,Fernando López‐Ríos,Vincent Ninane,Włodzimierz Olszewski,Helmut Popper,Sauleda Jaume,Philipp A. Schnabel,Luc Thiberville,Florian Laenger	2011	167
13	Loss of miR-200c Expression Induces an Aggressive, Invasive, and Chemoresistant Phenotype in Non–Small Cell Lung Cancer Molecular Cancer Research ·Paolo Ceppi,Giridhar Mudduluru,Regalla Kumarswamy,Ida Rapa,Giorgio V. Scagliotti,Mauro Papotti,Heike Allgayer	2010	256
14	Thymidylate Synthase But Not Excision Repair Cross-Complementation Group 1 Tumor Expression Predicts Outcome in Patients With Malignant Pleural Mesothelioma Treated With Pemetrexed-Based Chemotherapy Journal of Clinical Oncology ·Luisella Righi,Mauro Papotti,Paolo Ceppi,Andrea Billè,Elisa Bacillo,Luca Molinaro,Enrico Ruffini,Giorgio V. Scagliotti,Giovanni Selvaggi	2010	126
15	Effects of Src kinase inhibition induced by dasatinib in non–small cell lung cancer cell lines treated with cisplatin Molecular Cancer Therapeutics ·Paolo Ceppi,Mauro Papotti,Valentina Monica,Marco Lo Iacono,Silvia Saviozzi,Marisa Pautasso,Silvia Novello,Stefano Mussino,Enrico Bracco,Marco Volante,Giorgio V. Scagliotti	2009	51
16	Non–Small Cell Lung Cancer Exhibits Transcript Overexpression of Genes Associated with Homologous Recombination and DNA Replication Pathways Cancer Research ·Silvia Saviozzi,Paolo Ceppi,Silvia Novello,P Ghio,Marco Lo Iacono,P. Borasio,Alberto Cambieri,Marco Volante,Mauro Papotti,Raffaele Calogero,Giorgio V. Scagliotti	2009	58
17	Human ASH1 expression in prostate cancer with neuroendocrine differentiation Modern Pathology ·Ida Rapa,Paolo Ceppi,Enrico Bollito,Rosj Rosas,Susanna Cappia,Elisa Bacillo,F. Porpiglia,Alfredo Berruti,Mauro Papotti,Marco Volante	2008	39
18	Excision Repair Cross Complementing-1 and Topoisomerase IIα Gene Expression in Small-Cell Lung Cancer Patients Treated with Platinum and Etoposide: A Retrospective Study Journal of Thoracic Oncology ·Paolo Ceppi,Marina Longo,Marco Volante,Silvia Novello,Susanna Cappia,Elisa Bacillo,Giovanni Selvaggi,Silvia Saviozzi,Raffaele Calogero,Mauro Papotti,Giorgio V. Scagliotti	2008	35
19	Epidermal growth factor ligand/receptor loop and downstream signaling activation pattern in completely resected nonsmall cell lung cancer Cancer ·Marco Volante,Silvia Saviozzi,Ida Rapa,Paolo Ceppi,Susanna Cappia,Raffaele Calogero,Silvia Novello,P. Borasio,Mauro Papotti,Giorgio V. Scagliotti	2007	16
20	Basaloid adenocarcinoma. A new variant of pulmonary adenocarcinoma Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·Valerio Marci,Marco Volante,Susanna Cappia,Luisella Righi,Corrado Novello,Giorgio V. Scagliotti,Élisabeth Brambilla,Mauro Papotti	2007	10

About Mauro Papotti

Mauro Papotti is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Oncology, having authored 96 papers that have together received 4.6k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (35 papers), Occupational and environmental lung diseases (17 papers), Medical Imaging and Pathology Studies (17 papers), Prostate Cancer Treatment and Research (16 papers), Cancer Genomics and Diagnostics (15 papers), Lung Cancer Research Studies (13 papers), Prostate Cancer Diagnosis and Treatment (12 papers) and Lung Cancer Diagnosis and Treatment (12 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (2.7k citations), Cancer Research (1.1k citations) and Oncology (1.7k citations). Mauro Papotti has collaborated with scholars based in Italy, United States and Japan. Frequent co-authors include Giorgio V. Scagliotti, Paolo Ceppi, Silvia Novello, Luisella Righi, Marco Volante, Giulio Rossi, Giuseppe Pelosi, Marco Lo Iacono, Mattia Barbareschi and Valentina Monica. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact